Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07862439 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Biomarker-guided Reduction of Immunosuppression in Liver Transplant Recipients (BRITRE)

Study acronym: BRITRE
StatusNot Yet Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Researchers are interested in determining whether it is safe to reduce anti-rejection medication by approximately 50% after liver transplantation and whether special blood tests called biomarkers can identify early signs that the body is starting to attack the new liver before it gets hurt.
Trial Details
NCT Number NCT07862439
Lead Sponsor University of Pennsylvania
Collaborators: National Institute of Allergy and Infectious Diseases (NIAID)
Conditions Liver Diseases
Enrollment 180 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov